Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CURB: Buprenorphine for Cocaine Dependence
NCT01402492Phase 3Completed
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buprenorphine in cocaine dependence (3 arms), sponsored by University of California, Los Angeles. Primary endpoint: Cocaine Use Days as Measured by Self-report, Corroborated by Thrice-weekly Urine Drug Screens. Started Sep 2011; status: completed.
02
Drugs
buprenorphine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT01402492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01402492.